Citigroup’s Signify Health, Inc. SGFY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-64,069
Closed -$1.84M 6015
2022
Q4
$1.84M Sell
64,069
-24,742
-28% -$714K ﹤0.01% 2108
2022
Q3
$2.59M Sell
88,811
-69,994
-44% -$1.61M ﹤0.01% 1957
2022
Q2
$2.19M Buy
158,805
+152,162
+2,291% +$2.14M ﹤0.01% 2039
2022
Q1
$120K Sell
6,643
-1,774
-21% -$25.4K ﹤0.01% 4333
2021
Q4
$120K Buy
8,417
+452
+6% +$7K ﹤0.01% 4640
2021
Q3
$142K Buy
7,965
+4,618
+138% +$119K ﹤0.01% 4279
2021
Q2
$102K Buy
3,347
+1,338
+67% +$36.8K ﹤0.01% 4512
2021
Q1
$59K Buy
+2,009
New +$62.2K ﹤0.01% 4616

Other funds holding SGFY

Citigroup's SGFY Position: Q1 2023 in Review

Citigroup sold out of Signify Health, Inc. (SGFY) in Q1 2023, closing a stake of 64,069 shares — an estimated $1.84M sold.

Citigroup first reported a position in SGFY in Q1 2021 and held it in 8 quarters. The position peaked at $2.59M in Q3 2022. 5 funds tracked by Wall St. Rank hold SGFY as of Q1 2023.

  • Citigroup reported no remaining Signify Health, Inc. position as of Q1 2023 after selling out during the quarter.
  • Citigroup sold 64,069 Signify Health, Inc. shares in Q1 2023, an estimated $1.84M.
  • Citigroup first reported a position in Signify Health, Inc. in Q1 2021 and held it in 8 quarters.
  • Citigroup's Signify Health, Inc. position peaked at $2.59M in Q3 2022.
  • 5 funds tracked by Wall St. Rank held Signify Health, Inc. as of Q1 2023.

Based on Citigroup's 13F filing for Q1 2023, filed 11 May 2023.